Dr. Peter Campochiaro, the Eccles Professor of Ophthalmology and Neurosciences at the Wilmer Eye Institute at The Johns Hopkins University in Baltimore will present patient case scenarios which will: describe the potential benefits and risks of intraocular ant-VEGF drugs in treating retinal vein occlusions; determine patient characteristics that favor one treatment modality over another; explain the potential benefits and risks of intraocular steroids in treating retinal vein occlusions